Estimating individual lifetime benefit and bleeding risk of adding oral anticoagulation to aspirin for patients with stable cardiovascular disease: directions from COMPASS?-Reference-Cited by-同舟云学术

Estimating individual lifetime benefit and bleeding risk of adding oral anticoagulation to aspirin for patients with stable cardiovascular disease: directions from COMPASS?

Published:2019-09-01 Issue:46 Volume:40 Page:3779-3781
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Kozieł Monika¹²,Lip Gregory Y H¹²³^ORCID

Affiliation:

1. Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, 6 West Derby Street, Liverpool, UK

2. Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Medical University of Silesia, Silesian Centre for Heart Diseases, Zabrze, Poland

3. Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/40/46/3779/31247528/ehz517.pdf

Reference16 articles.

1. Rivaroxaban with or without aspirin in stable cardiovascular disease;Eikelboom;N Engl J Med,2017

2. Rivaroxaban in patients with a recent acute coronary syndrome;Mega;N Engl J Med,2012

3. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point;Ndrepepa;J Am Coll Cardiol,2008

4. Antithrombotic therapy for acute coronary syndrome: past, present and future;Sibbing;Thromb Haemost,2017

5. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS);Valgimigli;Eur Heart J,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Panax notoginseng preparation plus aspirin versus aspirin alone on platelet aggregation and coagulation in patients with coronary heart disease or ischemic stroke: A meta-analysis of randomized controlled trials;Frontiers in Pharmacology;2022-12-07

2. Development and Validation of the HPLC Method for Quantification of the Innovative Drug DD217, Factor Xa Inhibitor, in Rat Plasma for a Pharmacokinetic Study;Drug development & registration;2022-05-30

3. Aspirin and low-dose rivaroxaban – the dual pathway concept in patients with stable atherosclerotic disease: a comprehensive review;Expert Review of Cardiovascular Therapy;2020-09-01

4. Between Scylla and Charybdis: combining anticoagulants with platelet inhibitors and outcome;European Heart Journal;2019-12-07